clinical-stage pharmaceutical

4 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Unknown

ENA Respiratory Bolsters Board With GSK Veteran Melissa Faris as Director

Clinical-stage biotech ENA Respiratory appoints Melissa Faris, GSK respiratory veteran, as independent director to strengthen governance during INNA-051 development.
GSKimmunologyrespiratory infections
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Artelo Biosciences Raises $11M in Private Placement to Fund Operations

Artelo Biosciences closes $11M private placement at $3.45/share, raising capital for operations and debt repayment with additional warrant upside.
ARTLprivate placementwarrant exercise
The Motley FoolThe Motley Fool··Jonathan Ponciano

First Turn Management Establishes $35M Stake in Clinical-Stage Biotech Terns

First Turn Management invests $35M in clinical-stage biotech Terns Pharmaceuticals, acquiring 4.03% stake. Stock surged 826% year-over-year on cancer drug trial progress.
TERNdrug developmentstock surge
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Nasus Pharma Closes $15M Capital Raise to Fund Epinephrine Product Development

Nasus Pharma raises $15M to advance intranasal epinephrine product toward FDA trials. Funds support NS002 development and pipeline expansion.
NSRXprivate placementcapital raise